GxPinnacle Logo
Skip to content

What Do Inspectors Check for Vendor Performance Monitoring in Pharmacovigilance?

Pharmacovigilance systems must monitor vendor performance using defined KPIs, audits, and oversight processes. Regulators expect continuous monitoring, trend analysis, and escalation where vendor performance deviates from requirements.

For: Founders, CEOs & MDs·PV Leads·QA/Compliance·Scientists tasked with documentation

Alignment: Global pharmacovigilance principles (ICH-aligned) and inspection practices

Most useful when: Preparing for inspection, setting up a process, or closing a documentation gap

Key points

  • Pharmacovigilance vendors must be monitored continuously using defined performance metrics.
  • Key performance indicators must assess timeliness, quality, and compliance of vendor activities.
  • Performance monitoring must include review of case processing timelines, data quality, and regulatory compliance.
  • Results must be reviewed regularly and discussed through governance processes.
  • Performance issues must trigger escalation and corrective action.
  • Inspection-ready evidence must demonstrate active and ongoing monitoring of vendor performance.

What inspectors expect

Each point below should be supported by controlled documents and traceable records.

  • Vendor performance must be monitored using defined metrics.
  • Performance monitoring must cover timeliness, quality, and compliance.
  • Performance data must be reviewed regularly.
  • Performance issues must be identified and addressed.
  • The MAH must maintain visibility and control over vendor performance.

Summary

Inspectors assess whether pharmacovigilance vendors are monitored through structured performance metrics and oversight processes. They typically review KPIs, audit results, trend analysis, and evidence that performance issues are identified and managed effectively.

Common questions

These are the questions this page is designed to answer directly.

  • How do you monitor pharmacovigilance vendor performance?
  • What KPIs are used for PV vendor monitoring?
  • What do inspectors check for vendor performance monitoring?
  • How are CROs monitored in pharmacovigilance?
  • What metrics should be tracked for PV vendors?
  • How do you ensure vendor compliance in pharmacovigilance?
  • What is vendor oversight monitoring in PV?
  • How are vendor performance issues identified?
  • How do inspectors verify vendor performance monitoring?
  • What evidence is required for PV vendor monitoring?

Evidence objects inspectors expect

Vendor KPI Reports

  • ICSR reporting timeliness metrics
  • Case quality scores and QC error rates
  • Follow-up completion rates
  • Compliance with agreed service levels
  • Trend analysis of performance over time

Vendor Oversight Plan

  • Defined monitoring activities and frequency
  • Governance and communication schedule
  • Roles responsible for vendor oversight
  • Risk-based monitoring approach

Performance Review and Governance Records

  • Regular vendor review meetings
  • Discussion of KPI performance and trends
  • Documentation of performance issues
  • Action items arising from reviews

Audit and Quality Review Outputs

  • Vendor audit reports
  • Findings related to performance and compliance
  • CAPA triggered by performance issues
  • Follow-up verification of improvements

Issue Logs and Escalation Records

  • Documented vendor performance issues
  • Severity classification of issues
  • Escalation to senior management
  • Tracking of issue resolution

Regulatory Basis (Primary Sources)

  • GVP Module I – requirement for oversight of outsourced pharmacovigilance activities
  • GVP Module VI – need for compliant handling of safety data through controlled processes
  • ICH E2D – expectations for maintaining compliant safety data management systems
  • MHRA GPvP guidance – expectations for monitoring vendor performance
  • FDA pharmacovigilance guidance – requirement to ensure compliance of outsourced activities

Typical Inspection Questions (What Inspectors Ask)

  • How do you monitor your vendor's performance?
  • What KPIs do you track for vendor activities?
  • Show me performance reports for this vendor.
  • How do you identify and manage performance issues?
  • What actions were taken when performance dropped?

Failure patterns

Vendor performance is not monitored systematically.

KPIs are defined but not reviewed or acted upon.

Performance issues are identified but not escalated.

No evidence of trend analysis or governance review.

The MAH lacks visibility of vendor performance.

What good looks like

  • Defined KPIs covering all critical vendor activities.
  • Regular monitoring and reporting of vendor performance.
  • Trend analysis identifying performance issues early.
  • Governance processes reviewing performance data.
  • Clear escalation and CAPA processes for performance failures.

Operationalisation

  • Define KPIs aligned with vendor responsibilities.
  • Track performance metrics regularly.
  • Review KPI results through governance meetings.
  • Identify and escalate performance issues.
  • Implement CAPA where required.
  • Ensure ongoing oversight of vendor performance.

Need regulatory documentation today?

Save time and reduce inspection risk with structured, pre-built process-ready documentation.
Created by industry professionals, adaptable to your organisation.

Related pre-built documentation inside the app

Get AccessLog In

FAQ

How do you monitor pharmacovigilance vendor performance?

Vendor performance is monitored using defined KPIs, regular reporting, governance reviews, audits, and issue tracking processes.

What KPIs are used for PV vendor monitoring?

Common KPIs include ICSR reporting timeliness, case quality, follow-up completion rates, and compliance with regulatory timelines.

How do you measure pharmacovigilance vendor performance?

Vendor performance is measured using defined KPIs such as ICSR reporting timeliness, case quality, follow-up completion, compliance with service levels, and audit outcomes, supported by regular review and trend analysis.

Do inspectors review vendor performance monitoring?

Yes. Inspectors review KPI reports, audit outputs, and governance records to confirm that vendor performance is actively monitored.

What happens if vendor performance drops?

Performance issues should be escalated, investigated, and addressed through corrective and preventive actions.

How often should vendor performance be reviewed?

Vendor performance is typically reviewed monthly or quarterly depending on risk and service criticality.

What evidence is required for vendor performance monitoring?

Evidence includes KPI reports, meeting minutes, audit reports, issue logs, and CAPA documentation.

Sources

Primary guidance used to inform this map. This page is a structured interpretation layer; always validate against the original source documents.

European Medicines Agency (EMA)

  • Guideline on good pharmacovigilance practices (GVP) – Module I
    View source
  • Guideline on good pharmacovigilance practices (GVP) – Module VI
    View source

FDA

ICH

MHRA